Krystal Biotech, Inc. KRYS Return on invested capital

Return on invested capital at other companies

Ultragenyx PharmaceuticalRARE

-475.4%+443pp

Viridian Therapeutics, Inc.VRDN

-78.5%-6.2pp

RegenxbioRGNX

-103.9%+612pp

Zevra Therapeutics, Inc.ZVRA

71.7%+48.7pp

Kyverna Therapeutics, Inc.KYTX

-94.5%-4.6pp

FAQ

What is Krystal Biotech, Inc.'s return on invested capital?

Krystal Biotech, Inc. (KRYS) reported return on invested capital of 24.3% in Q1 2026.

How has Krystal Biotech, Inc.'s return on invested capital changed year-over-year?

Krystal Biotech, Inc.'s return on invested capital increased by 41.2% year-over-year, from 17.2% to 24.3%.

What is the long-term trend for Krystal Biotech, Inc.'s return on invested capital?

Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s return on invested capital has grown at a -29.9% compound annual growth rate (CAGR), from -142.2% to 24%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.